Breanne Gibson
Senior Scientist, Clinical Development Cumberland Pharmaceuticals
Breanne Gibson, Ph.D., is a Senior Clinical Scientist at Cumberland Pharmaceuticals, where she supports preclinical and clinical studies for both commercial and investigational products, with a focus on rare pulmonary diseases, including idiopathic pulmonary fibrosis. She has over ten years of experience in clinical and translational research with over four years in industry settings.
Dr. Gibson’s expertise spans clinical study design, protocol development, regulatory process, and data analysis. She also oversees relationships with key opinion leaders and clinical trial sites to advance therapeutic development across critical unmet needs.
She holds a Ph.D. in Pharmacology from Vanderbilt University and a Bachelor’s degree in biology from Cedarville University. Dr. Gibson is dedicated to advancing IPF research through rigorous, translational approaches to improve patient outcomes.
Seminars
- Exploring how Cumberland amended its IPF trial to allow newly approved therapies as background treatment, ensuring patients can access the latest options while maintaining scientific rigor in evaluating investigational therapies
- Understanding how patient demand for newly approved drugs can influence recruitment, retention, and protocol design, and how proactive site engagement and investigator feedback informed trial modifications
- Lessons from patient experiences with antifibrotics and newer therapies, highlighting how tolerability challenges can influence treatment decisions, trial participation, and the interpretation of clinical outcomes
